Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julieta Lazarte

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Expert Review of Cardiovascular Therapy|July 15, 2021
Volanesorsen for treatment of familial chylomicronemia syndromeJulieta Lazarte, Robert A Hegele
Current Opinion in Lipidology|June 11, 2020
Can genetic testing help in the management of dyslipidaemias?Julieta Lazarte, Robert A Hegele
Canadian Journal of Diabetes|September 16, 2019
Dyslipidemia Management in Adults With DiabetesJulieta Lazarte, Robert A Hegele
Current Opinion in Lipidology|February 19, 2021
Editorial comment: hazards of interpreting genetic reportsJulieta Lazarte, Robert A Hegele
Current Opinion in Lipidology|January 17, 2019
Cannabis effects on lipoproteinsJulieta Lazarte, Robert A Hegele
Annals of Internal Medicine|February 18, 2020
Regression of Xanthelasmas With Statin Treatment in a Normolipidemic PatientJulieta Lazarte, Robert A Hegele
NPJ Genomic Medicine|October 12, 2019
Can one overcome "unhealthy genes"?Julieta Lazarte, Robert A Hegele
The Canadian Journal of Cardiology|July 9, 2020
Pediatric Dyslipidemia-Beyond Familial HypercholesterolemiaJulieta Lazarte, Robert A Hegele
European Journal of Preventive Cardiology|February 24, 2021
DNA sequencing in familial hypercholesterolaemia: the next generationJulieta Lazarte, Robert A Hegele
NPJ Genomic Medicine|December 4, 2021
Lamin A/C missense variants: from discovery to functional validationJulieta Lazarte, Robert A Hegele
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Expert Review of Cardiovascular Therapy|July 15, 2021
Volanesorsen for treatment of familial chylomicronemia syndromeJulieta Lazarte, Robert A Hegele
Current Opinion in Lipidology|June 11, 2020
Can genetic testing help in the management of dyslipidaemias?Julieta Lazarte, Robert A Hegele
Canadian Journal of Diabetes|September 16, 2019
Dyslipidemia Management in Adults With DiabetesJulieta Lazarte, Robert A Hegele
Current Opinion in Lipidology|February 19, 2021
Editorial comment: hazards of interpreting genetic reportsJulieta Lazarte, Robert A Hegele
Current Opinion in Lipidology|January 17, 2019
Cannabis effects on lipoproteinsJulieta Lazarte, Robert A Hegele
Annals of Internal Medicine|February 18, 2020
Regression of Xanthelasmas With Statin Treatment in a Normolipidemic PatientJulieta Lazarte, Robert A Hegele
NPJ Genomic Medicine|October 12, 2019
Can one overcome "unhealthy genes"?Julieta Lazarte, Robert A Hegele
The Canadian Journal of Cardiology|July 9, 2020
Pediatric Dyslipidemia-Beyond Familial HypercholesterolemiaJulieta Lazarte, Robert A Hegele
European Journal of Preventive Cardiology|February 24, 2021
DNA sequencing in familial hypercholesterolaemia: the next generationJulieta Lazarte, Robert A Hegele
NPJ Genomic Medicine|December 4, 2021
Lamin A/C missense variants: from discovery to functional validationJulieta Lazarte, Robert A Hegele
Pageof 4